CELYAD ONCOLOGY (CYAD.BR) Stock Technical Analysis
Europe - Euronext Brussels - EBR:CYAD - BE0974260896 - Common Stock
We assign a technical rating of 1 out of 10 to CYAD. CYAD's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
- Both the long and short term trends are negative. It is better to avoid buying stocks with negative trends.
- 97% of all other stocks performed better in the past year than CYAD.
- CYAD is part of the Biotechnology industry. There are 85 other stocks in this industry, of which 61% are performing better than CYAD.
- CYAD is currently trading near the lower end of its 52 week range, which is not a good sign. Certainly not because the S&P500 Index is trading near new 52 week highs at the moment.
- In the last month CYAD has a been trading in the 0.17 - 0.19 range, which is quite wide. It is currently trading near the lows of this range.
- Warning: CYAD has an average volume of 17119 traded shares per day. This is quite low and it might be dangerous to invest in illiquid stocks.
CYAD has a bad technical rating, but it does show a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is a resistance zone just above the current price starting at 0.18. Right above this resistance zone may be a good entry point.
More info and screens
0.17
When analyzing the resistance we notice 3 important areas.
- A resistance zone ranging from 0.18 to 0.18. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
- Resistance @0.21 from a horizontal line in the daily time frame.
- Resistance @0.23 from a trend line in the weekly time frame.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for CYAD.BR is down. |
| ChartMill Short Term Trend Indicator | DOWN | NEGATIVE | The short term trend for CYAD.BR is down. |
| ChartMill Relative Strength | 3.84 | NEGATIVE | CYAD.BR has a low relative strength, it was outperformed by 96.16% off all stocks on the market. |
| Simple Moving Average/SMA (20) | UP | MIXED | The current price of CYAD.BR is below the rising SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of CYAD.BR is below a declining SMA(50). |
| Simple Moving Average/SMA (200) | DOWN | NEGATIVE | The current price of CYAD.BR is below a declining SMA(200). |
| Relative Strength Index/RSI (14) | 41.71 | NEUTRAL | The RSI value for CYAD.BR is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0 | NEGATIVE | The MACD value suggests CYAD.BR has a negative trend, although the MACD value is rising. |
| Stochastics (14,3) | 10.83 | OVERSOLD | The low Stochastics value suggests CYAD.BR may be oversold. |
| Average True Range in percent/ATR (20) | 5.42 | HIGH VOLATILITY | The high ATR as a percentage value for CYAD.BR suggests high volalility. |
| Average Directional Index/ADX (14) | 20.67 | NEUTRAL | The ADX value for CYAD.BR suggests a possible start of a new trend. |
EBR:CYAD (1/29/2026, 7:00:00 PM)
0.1715
0 (0%)
CELYAD ONCOLOGY / CYAD.BR FAQ
What is the ChartMill technical rating of CELYAD ONCOLOGY (CYAD.BR) stock?
ChartMill assigns a technical rating of 1 / 10 to CYAD.BR.
What is the trend direction for CYAD stock?
The current trend direction for CELYAD ONCOLOGY (CYAD.BR) is Bearish.
What is the RSI signal for CYAD stock?
CELYAD ONCOLOGY (CYAD.BR) has an RSI value of 41.7137. This indicates that the stock is currently neutral.
Can you provide the buy/sell signal for CELYAD ONCOLOGY?
The buy/sell signal for CELYAD ONCOLOGY (CYAD.BR) is sell as both the short term and long term trends are negative.
What are the support and resistance levels for CELYAD ONCOLOGY (CYAD.BR) stock?
CELYAD ONCOLOGY (CYAD.BR) has a resistance level at 0.18. Check the full technical report for our detailed analysis of CYAD.BR support and resistance levels.